Labeling And Liability: FDA Wary Of “Over-Warning,” “Piling On” By Lawyers

Trial lawyers should work with FDA to focus product liability actions on cases where manufacturers appear to be withholding information, Commissioner McClellan suggested during the National Community Pharmacists Association legislative conference May 19 in Washington, D.C